Cytosorbents (CTSO) Inventory Average (2011 - 2026)

Cytosorbents' Inventory Average history runs 15 years deep, the most recent figure standing at $4.9 million for Q1 2026.

• Quarterly Inventory Average rose 69.94% year-over-year to $4.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.9 million (up 69.94% YoY) and the FY2025 annual result came in at $4.0 million, up 31.38% from the prior year.
• Inventory Average was $4.9 million for Q1 2026 at Cytosorbents, up from $4.6 million in the prior quarter.
• Across five years, Inventory Average topped out at $5.2 million in Q2 2022 and bottomed at $1.9 million in Q2 2023.
• A 5-year average of $3.7 million and a median of $3.6 million in 2024 frame the typical range for Inventory Average.
• Annual changes were most pronounced in 2023 — Inventory Average tumbled 63.82% — and 2024, when it surged 113.58%.
• Cytosorbents' Inventory Average stood at $3.5 million in 2022, then dropped by 9.28% to $3.2 million in 2023, then retreated by 5.86% to $3.0 million in 2024, then soared by 55.42% to $4.6 million in 2025, then grew by 5.15% to $4.9 million in 2026.
• Business Quant data shows CTSO's Inventory Average at $4.9 million in Q1 2026, $4.6 million in Q4 2025, and $3.9 million in Q3 2025.